Tegoprazan for planned surgery patients under general anesthesia
Treatments studied
This trial tests whether a stomach-acid-reducing drug (tegoprazan) helps prevent complications during planned surgeries under general anesthesia. It is for adults aged 20–69 with a non-emergency surgery and a BMI under 35.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning a surgery that requires general anesthesia (medicine to make you sleep).
- You are between 20 and 69 years old.
- Your overall health is classified as ASA I, II, or III (healthy to stable chronic illness).
- Your surgery is not an emergency.
- Your body mass index (BMI) is less than 35.
- You have no history of drug abuse or dependence, and no known allergy to anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.
This trial studies how two medicines, toprazole and aspirin, interact in healthy men. You'll take both and have your blood tested to see how your body handles them.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
This study tests a stomach-protecting medicine called tegoprazan for people who have had a stroke and are starting antiplatelet therapy. It aims to prevent stomach complications like ulcers or bleeding.
This study tests whether a medication called tegoprazan can help doctors diagnose acid reflux (GERD). Eligible participants will take the medication and track their symptoms to see if it improves them.
Hear when a new General Anesthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.